Target intelligence / Profile preview

RNA, 5S ribosomal pseudogene 243 (RNA5SP243)

Target
RNA5SP243
Molecular classification
Other, Pseudogene, Non-coding RNA
01

Overview

RNA, 5S ribosomal pseudogene 243 (RNA5SP243) is a human pseudogene belonging to the family of 5S ribosomal RNA pseudogenes. Pseudogenes are genomic DNA sequences similar to normal genes but are nonfunctional; they do not encode functional RNAs or proteins. The 5S ribosomal RNA, from which these pseudogenes derive, is a component of the large ribosomal subunit and plays a structural and organizational role within the ribosome; however, pseudogenes such as RNA5SP243 do not contribute to these biological functions due to the accumulation of disabling mutations and loss of transcriptional activity. This pseudogene is not known to have any relevance as a therapeutic target, is not associated with any pharmacological mechanism, and does not serve as a biomarker or have identified roles in disease. The designation as a "pseudogene" reflects that RNA5SP243 is a non-functional relic of the functional 5S ribosomal RNA gene family. Pseudogenes are assigned names to reflect their homology to functional coding genes, usually with a “P” designation. RNA5SP243 is not expressed as a functional RNA and is not a receptor, enzyme, or known therapeutic or diagnostic target. No known drugs interact with this pseudogene, and it is not involved in molecular mechanisms relevant to disease or therapy. In summary, RNA, 5S ribosomal pseudogene 243 (RNA5SP243) is a non-functional pseudogene, not a molecular target or biomarker, and has no disease associations or pharmacological relevance.

Other names
RN5S243RNA5SP243RNA, 5S ribosomal 243

Beyond the preview

Go deeper on RNA, 5S ribosomal pseudogene 243 (RNA5SP243).

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Drug pipeline

Full profile access

Explore the programs pursuing this target and their development progress.

  • Drug candidates
  • Developers
  • Development stage

Clinical trials

Full profile access

Follow the clinical studies evaluating therapies directed at this target.

  • Trial design
  • Status
  • Readouts

Competitive landscape

Full profile access

Compare approaches across drug candidates, modalities, and indications.

  • Programs
  • Modalities
  • Indications

Literature & evidence

Full profile access

Investigate the research and source evidence behind target biology and development.

  • Publications
  • Sources
  • Analysis

Patents

Full profile access

Explore patent activity around therapies and technologies addressing this target.

  • Patents
  • Assignees
  • Technologies

Research & analysis

Full profile access

Connect target biology, drug development, and emerging evidence in your research.

  • Biology
  • Development news
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on RNA, 5S ribosomal pseudogene 243 (RNA5SP243).

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call